BCDA
BioCardia, Inc.
1.21
1 x 1.20
2 x 1.53
bid
ask
+
0.02
1.46%
09:51 AM
timesize
Ytd-3.41%
1y-41.95%
1.19
day range
1.24
0.78
52 week range
2.45
Open1.19Prev Close1.19Low1.19High1.24Mkt Cap17.86M
Vol66.05KAvg Vol3.09MEPS-0.85P/EN/AForward P/E-1.57
Beta1.27Short Ratio1.41Inst. Own2.21%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg1.02200-d Avg1.241yr Est25.00

BCDA News

benzinga.com
BioCardia CEO Issued Shareholder Letter To Provide Update; Milestone Includes Submission For Japan's

Dear Fellow Shareholders,Upon completion of our recent capital raise, I am providing this update on

BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
globenewswire.com
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities

SUNNYVALE, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leade

What's Going On With BioCardia Stock Tuesday?
benzinga.com
What's Going On With BioCardia Stock Tuesday?

BioCardia (BCDA) stock slides after a $4.4M share dilution, but analysts spot massive upside. Check

benzinga.com
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy an

benzinga.com
BioCardia Sells 3,509,604 Shares At Average Price Of $1.279 On June 5; No Warrants Issued In Capital

Net proceeds anticipated to extend cash runway into first quarter of 2027 beyond expected Japan PMDA

BioCardia Announces $4.4 Million Financing
globenewswire.com
BioCardia Announces $4.4 Million Financing

Net proceeds anticipated to extend cash runway into first quarter of 2027 beyond expected Japan PMDA

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Why Is BioCardia Stock Gaining Friday?
benzinga.com
Why Is BioCardia Stock Gaining Friday?

BioCardia Inc. (NASDAQ:BCDA) stock is up on Friday as the company is confirming progress toward pote

Why Is BioCardia Stock Gaining Friday?
benzinga.com
Why Is BioCardia Stock Gaining Friday?

BioCardia stock breaks above its 200-day moving average on huge FDA news. Can BCDA clear the $1.50 r

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
BioCardia Receives FDA Confirmation For Its Biologics Evaluation And Research On CardiAMP Cell Thera

BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the t

FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF
globenewswire.com
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFr

SUNNYVALE, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leade

benzinga.com
BioCardia Announces Presentation Of Data From CardiAMP Minimally-Invasive Chronic Myocardial Ischemi

Results presented by Dr. Raval, on behalf of the CardiAMP CMI Investigators, showed that the minimal

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency
globenewswire.com
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed D

– Positive CardiAMP CMI Trial open-label cohort results demonstrated opportunity for locally deliver

BioCardia, Inc. (BCDA) Q1 2026 Earnings Call Transcript
seekingalpha.com
BioCardia, Inc. (BCDA) Q1 2026 Earnings Call Transcript

BioCardia, Inc. (BCDA) Q1 2026 Earnings Call Transcript

BioCardia Q1 2026 Earnings Call: Complete Transcript
benzinga.com
BioCardia Q1 2026 Earnings Call: Complete Transcript

benzinga.com
BioCardia Q1 EPS $(0.21) Misses $(0.17) Estimate

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.21) per share which missed the analyst cons

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results
globenewswire.com
BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

SUNNYVALE, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader

Earnings Scheduled For May 15, 2026
benzinga.com
Earnings Scheduled For May 15, 2026

BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
globenewswire.com
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of c

benzinga.com
BioCardia Says FDA Raised No Safety Concerns, Outlines Two Clearance Pathways For Helix Catheter Sys

BioCardia®, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the tr

BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways
globenewswire.com
BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways

SUNNYVALE, Calif. , May 08, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
globenewswire.com
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Appr

SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global lead

benzinga.com
BioCardia Files Request For FDA Meeting Related To Approval For CardiAMP System For Ischemic Chronic

BioCardia®, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the tr

Tamboran Farmout Pilot Area and BCDA Acreage for Significant Premium in Acreage Value
businesswire.com
Tamboran Farmout Pilot Area and BCDA Acreage for Significant Premium in Acreage Value

NEW YORK--(BUSINESS WIRE)--Tamboran Resources Corporation (NYSE: TBN, ASX: TBN): Tamboran Resources

BioCardia Q4 Earnings Call Highlights
defenseworld.net
BioCardia Q4 Earnings Call Highlights

BioCardia (NASDAQ: BCDA) executives on Tuesday outlined new clinical data for the company's lead cel

BioCardia, Inc. (BCDA) Q4 2025 Earnings Call Transcript
seekingalpha.com
BioCardia, Inc. (BCDA) Q4 2025 Earnings Call Transcript

BioCardia, Inc. (BCDA) Q4 2025 Earnings Call Transcript

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
BioCardia Q4 EPS $(0.06) Beats $(0.17) Estimate

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.06) per share which beat the analyst consen

BioCardia Reports 2025 Business Highlights and Financial Results
globenewswire.com
BioCardia Reports 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leade

Earnings Scheduled For March 24, 2026
benzinga.com
Earnings Scheduled For March 24, 2026

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026
globenewswire.com
BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of

BioCardia (NASDAQ:BCDA) Stock Price Down 3.9%  – Time to Sell?
defenseworld.net
BioCardia (NASDAQ:BCDA) Stock Price Down 3.9% – Time to Sell?

Shares of BioCardia, Inc. (NASDAQ: BCDA - Get Free Report) fell 3.9% on Wednesday. The company trade

benzinga.com
The FDA Accepts Biocardia's Pre-submission Package For The Approval Of Its Helix Transendocardial De

BioCardia has had preliminary meetings with both FDA Center for Devices and Radiological Health (CDR

benzinga.com
BioCardia Completes Pre-Submission To FDA Under Q-Submission Program For Approval Of Helix Transendo

BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatme

BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart
globenewswire.com
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for The

SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
BioCardia Completes Third Preliminary Clinical Consultation With Japan's PMDA On CardiAMP Cell Thera

BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatm

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
globenewswire.com
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with J

SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a developer of

BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress
globenewswire.com
BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress

SUNNYVALE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader

benzinga.com
BioCardia Q3 EPS $(0.24) Beats $(0.25) Estimate

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.24) per share which beat the analyst consen

Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For November 12, 2025

Earnings Outlook For BioCardia
benzinga.com
Earnings Outlook For BioCardia

benzinga.com
BioCardia Updates ATM Offering, Raising Maximum Aggregate Sale To $5,309,253

This prospectus supplement updates and amends certain information in our base prospectus, dated Dece

benzinga.com
BioCardia Regains Compliance With Nasdaq Listing Requirements

BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatme

benzinga.com
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy an

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gold Falls Over 1%; Darden Posts Downbeat Earnings
benzinga.com
Gold Falls Over 1%; Darden Posts Downbeat Earnings

Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge
benzinga.com
Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session